nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—ADRB1—dilated cardiomyopathy	0.514	0.543	CbGaD
Bupranolol—ADRB2—dilated cardiomyopathy	0.432	0.457	CbGaD
Bupranolol—ADRB3—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00403	0.0944	CbGpPWpGaD
Bupranolol—ADRB3—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00327	0.0765	CbGpPWpGaD
Bupranolol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00234	0.0548	CbGpPWpGaD
Bupranolol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00194	0.0454	CbGpPWpGaD
Bupranolol—ADRB3—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00143	0.0334	CbGpPWpGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0012	0.0281	CbGpPWpGaD
Bupranolol—ADRB3—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00115	0.0271	CbGpPWpGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000971	0.0227	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000902	0.0211	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000878	0.0206	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000827	0.0194	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000727	0.017	CbGpPWpGaD
Bupranolol—Pirbuterol—ADRB1—dilated cardiomyopathy	0.000723	0.0699	CrCbGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000696	0.0163	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000685	0.0161	CbGpPWpGaD
Bupranolol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.000674	0.0158	CbGpPWpGaD
Bupranolol—Levobunolol—ADRB1—dilated cardiomyopathy	0.000645	0.0623	CrCbGaD
Bupranolol—Timolol—ADRB1—dilated cardiomyopathy	0.000615	0.0594	CrCbGaD
Bupranolol—Pirbuterol—ADRB2—dilated cardiomyopathy	0.000608	0.0588	CrCbGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000576	0.0135	CbGpPWpGaD
Bupranolol—Carteolol—ADRB1—dilated cardiomyopathy	0.000548	0.053	CrCbGaD
Bupranolol—Levobunolol—ADRB2—dilated cardiomyopathy	0.000542	0.0524	CrCbGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000535	0.0125	CbGpPWpGaD
Bupranolol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.000533	0.0125	CbGpPWpGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000524	0.0123	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000521	0.0122	CbGpPWpGaD
Bupranolol—Timolol—ADRB2—dilated cardiomyopathy	0.000517	0.05	CrCbGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00051	0.0119	CbGpPWpGaD
Bupranolol—Terbutaline—ADRB2—dilated cardiomyopathy	0.000496	0.0479	CrCbGaD
Bupranolol—ADRB3—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000494	0.0116	CbGpPWpGaD
Bupranolol—Nadolol—ADRB1—dilated cardiomyopathy	0.000489	0.0472	CrCbGaD
Bupranolol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000488	0.0114	CbGpPWpGaD
Bupranolol—Clenbuterol—ADRB1—dilated cardiomyopathy	0.000471	0.0455	CrCbGaD
Bupranolol—Carteolol—ADRB2—dilated cardiomyopathy	0.000461	0.0445	CrCbGaD
Bupranolol—Clenbuterol—TNF—dilated cardiomyopathy	0.000447	0.0432	CrCbGaD
Bupranolol—Bopindolol—ADRB1—dilated cardiomyopathy	0.000447	0.0432	CrCbGaD
Bupranolol—Salbutamol—ADRB1—dilated cardiomyopathy	0.000438	0.0423	CrCbGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000432	0.0101	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000427	0.01	CbGpPWpGaD
Bupranolol—Penbutolol—ADRB1—dilated cardiomyopathy	0.000426	0.0412	CrCbGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000422	0.00989	CbGpPWpGaD
Bupranolol—Nadolol—ADRB2—dilated cardiomyopathy	0.000411	0.0397	CrCbGaD
Bupranolol—ADRB3—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.0004	0.00938	CbGpPWpGaD
Bupranolol—Clenbuterol—ADRB2—dilated cardiomyopathy	0.000396	0.0383	CrCbGaD
Bupranolol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00038	0.00889	CbGpPWpGaD
Bupranolol—Bopindolol—ADRB2—dilated cardiomyopathy	0.000376	0.0363	CrCbGaD
Bupranolol—Salbutamol—ADRB2—dilated cardiomyopathy	0.000369	0.0356	CrCbGaD
Bupranolol—Penbutolol—ADRB2—dilated cardiomyopathy	0.000359	0.0346	CrCbGaD
Bupranolol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.000353	0.00826	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000352	0.00825	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000346	0.0081	CbGpPWpGaD
Bupranolol—Pindolol—ADRB1—dilated cardiomyopathy	0.000307	0.0297	CrCbGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000305	0.00716	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000287	0.00672	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000284	0.00665	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000275	0.00644	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000262	0.00613	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000262	0.00613	CbGpPWpGaD
Bupranolol—Pindolol—ADRB2—dilated cardiomyopathy	0.000258	0.025	CrCbGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000248	0.0058	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000243	0.0057	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000238	0.00557	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000236	0.00552	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000235	0.0055	CbGpPWpGaD
Bupranolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000226	0.00529	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000223	0.00522	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000209	0.0049	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000205	0.00481	CbGpPWpGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000205	0.00479	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000201	0.00471	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000199	0.00467	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000199	0.00467	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000191	0.00447	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000185	0.00434	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000181	0.00425	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000179	0.0042	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000177	0.00415	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000169	0.00395	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000165	0.00386	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00016	0.00374	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000155	0.00364	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000155	0.00364	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000153	0.00359	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000152	0.00356	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000152	0.00356	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000145	0.00341	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000144	0.00338	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000142	0.00332	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000141	0.00331	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000139	0.00327	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000137	0.00321	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000136	0.00319	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000132	0.0031	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000119	0.0028	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000118	0.00277	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000118	0.00277	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000117	0.00274	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000116	0.00271	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000116	0.00271	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000113	0.00265	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000113	0.00264	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000113	0.00264	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00011	0.00258	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000108	0.00253	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000108	0.00252	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000105	0.00245	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000104	0.00244	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000102	0.0024	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000102	0.0024	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000101	0.00238	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.51e-05	0.00223	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	9.21e-05	0.00216	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.1e-05	0.00213	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	8.9e-05	0.00208	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.66e-05	0.00203	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.63e-05	0.00202	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.41e-05	0.00197	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.22e-05	0.00193	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.22e-05	0.00192	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.86e-05	0.00184	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.46e-05	0.00175	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.8e-05	0.00159	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.68e-05	0.00157	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.68e-05	0.00157	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.54e-05	0.00153	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.54e-05	0.00153	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	6.4e-05	0.0015	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.38e-05	0.00149	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	6.26e-05	0.00147	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.21e-05	0.00146	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.09e-05	0.00143	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.08e-05	0.00142	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.07e-05	0.00142	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.07e-05	0.00142	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.04e-05	0.00142	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.04e-05	0.00142	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.94e-05	0.00139	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.94e-05	0.00139	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.89e-05	0.00138	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.79e-05	0.00136	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.64e-05	0.00132	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.62e-05	0.00132	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AGT—dilated cardiomyopathy	5.53e-05	0.0013	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.52e-05	0.00129	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.44e-05	0.00127	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.35e-05	0.00125	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.14e-05	0.0012	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.03e-05	0.00118	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.88e-05	0.00114	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.67e-05	0.00109	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.65e-05	0.00109	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.57e-05	0.00107	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.43e-05	0.00104	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.41e-05	0.00103	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.04e-05	0.000946	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.95e-05	0.000926	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.84e-05	0.0009	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.79e-05	0.000887	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.79e-05	0.000887	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.7e-05	0.000868	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.62e-05	0.000847	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.59e-05	0.00084	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.59e-05	0.00084	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.54e-05	0.000829	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.51e-05	0.000822	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.51e-05	0.000822	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.44e-05	0.000805	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RAC1—dilated cardiomyopathy	3.42e-05	0.000802	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.36e-05	0.000788	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.33e-05	0.000781	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.28e-05	0.000769	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AGT—dilated cardiomyopathy	3.27e-05	0.000766	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.26e-05	0.000764	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	3.21e-05	0.000753	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.16e-05	0.00074	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.76e-05	0.000646	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.7e-05	0.000632	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.63e-05	0.000617	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.62e-05	0.000613	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.28e-05	0.000534	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.27e-05	0.000532	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.25e-05	0.000527	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.23e-05	0.000522	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.2e-05	0.000515	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.03e-05	0.000476	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.99e-05	0.000465	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.94e-05	0.000455	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.9e-05	0.000445	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.56e-05	0.000366	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.56e-05	0.000364	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.53e-05	0.000358	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.35e-05	0.000315	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.32e-05	0.000309	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.24e-06	0.000216	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	9.03e-06	0.000212	CbGpPWpGaD
